This is Thomas Sullivan - Policy & Medicine Writing Staff's Typepad Profile.
Join Typepad and start following Thomas Sullivan - Policy & Medicine Writing Staff's activity
Join Now!
Already a member? Sign In
Thomas Sullivan - Policy & Medicine Writing Staff
Columbia, Maryland
Former political consultant who founded Rockpointe, Inc. a bio-medical education company in 1995.
Interests: marketing, politics, baseball, cycling, medicine, university of florida sports, medical education, track and cross country, driving kids to various practices
Recent Activity
Image
As we have reported, the Centers for Medicare and Medicaid Services (CMS) released its proposed rule to implement the Medicare Access and CHIP Reauthorization Act (MACRA). This is a significant rule with fundamental changes for Medicare. In our continuing coverage,... Continue reading
Posted 2 hours ago at Policy and Medicine
Image
For the third year now The Centers for Medicare and Medicaid Services (CMS) released its updated Physician and Other Supplier Utilization and Payment public use data, which includes summarized information on Part B services and procedures provided to Medicare beneficiaries.... Continue reading
Posted yesterday at Policy and Medicine
Image
Following last month's letter to the Pharmaceutical Research and Manufacturers of America (PhRMA), asking the group to "take financial responsibility for the drug industry's role in curtailing the opioid overdose epidemic," United States Senator Dick Durbin sent a letter to... Continue reading
Posted 4 days ago at Policy and Medicine
Image
Patient engagement and patient satisfaction have been a core principle of healthcare reform under ACA and MACRA. The Centers for Medicare and Medicaid Services (CMS) recently released for public comment its proposed physician-patient relationship categories, a first step toward a... Continue reading
Posted 5 days ago at Policy and Medicine
Image
The Department of Health and Human Services' Office of Civil Rights is stepping up its enforcement efforts. Phase 2 of its HIPAA compliance audit program has begun, and most covered entities and business associates are potential candidates. Also, first quarter... Continue reading
Posted 5 days ago at Policy and Medicine
Image
The United States House Committee on Energy and Commerce, Subcommittee on Health held a hearing on Tuesday, May 17, 2016, on the Centers for Medicare & Medicaid Services (CMS) proposed rule for Part B reimbursement rates. The hearing, titled "The... Continue reading
Posted 6 days ago at Policy and Medicine
Image
Vermont is soon to be the first state in the nation that requires pharmaceutical manufacturers to explain the reasons behind their price increases. This new law will be the result of recent legislation passed by the Vermont House and Senate,... Continue reading
Posted 7 days ago at Policy and Medicine
Image
Europe adopted a new Code of Ethical Business Practice late last year. This article explores the purpose of the new Code, standards found in the new code, as well as some material differences between this new Code and other Codes... Continue reading
Posted 7 days ago at Policy and Medicine
Image
Aegerion Pharmaceuticals has reached agreements in principle with the Department of Justice ("DOJ") and the Securities and Exchange Commission ("SEC"), relating to the ongoing investigations by both agencies into the Company's sales activities and disclosures related to JUXTAPID® capsules. The... Continue reading
Posted May 16, 2016 at Policy and Medicine
Image
Consolidation is happening in insurers and health systems throughout the country. A recent legal case in Louisiana sheds some light on where the judiciary may be going with this. In July of last year, the Biomedical Research Foundation Shreveport (BRFHH)... Continue reading
Posted May 16, 2016 at Policy and Medicine
Image
The American College of Cardiology recently held the 65th Annual Scientific Session and Expo, where several sessions focused on the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). During the session it was clear that CMS's intention was to... Continue reading
Posted May 13, 2016 at Policy and Medicine
Image
The Pharmaceutical Summit on Business and Compliance Issues in Managed Markets is set to take place June 8 through June 9, 2016, at the Grand Hyatt in Washington, D.C. The conference opens on the morning of June 8, 2016, with... Continue reading
Posted May 13, 2016 at Policy and Medicine
Image
The Senate Finance Committee Majority Staff recently issued a report entitled, “Physician Owned Distributorships: An Update on Key Issues and Areas of Congressional Concern.” This report serves as an update to the Committee’s 2011 Physician Owned Distributorship (POD) report, which... Continue reading
Posted May 12, 2016 at Policy and Medicine
Image
We have been talking about the opioid addiction in America for several months now, from Congressional hearings, to new Centers for Disease Control (CDC) guidelines, to what solutions exist for patients and their loved ones. In response to the epidemic,... Continue reading
Posted May 12, 2016 at Policy and Medicine
Image
The Campaign for Sustainable Rx Pricing (CSRxP) held a forum on "market-based policy solutions to curb rising drug prices" at the Newseum in Washington, D.C. John Rother of CSRxP started the conversation at the forum by discussing the importance of... Continue reading
Posted May 11, 2016 at Policy and Medicine
Image
Recently, the Centers for Medicare & Medicaid Services (CMS) published the final Quality Measure Development Plan which is a "strategic framework for [Medicare] clinician quality measurement development to support the new Merit-based Incentive Payment System (MIPS) and advanced alternative payment... Continue reading
Posted May 10, 2016 at Policy and Medicine
Image
Recent legal cases have highlighted the important issue of whether or not attorney-client privilege attaches to internal corporate investigations particularly if the investigations involve serious civil or criminal allegations relating to a breach of the public trust, including bribery, corruption,... Continue reading
Posted May 10, 2016 at Policy and Medicine
Image
The European Generics Medicines Association is undergoing a "rebranding" of sorts. They recently changed their name to "Medicines for Europe," and have expanded into value added medicines, "aimed at optimizing, rethinking, and reinventing existing medicines based on known molecules, addressing... Continue reading
Posted May 9, 2016 at Policy and Medicine
Image
MedTech Europe adopted a new Code of Ethical Business Practice late last year. This article explores the purpose of the new Code, standards found in the new code, as well as some material differences between this new Code and other... Continue reading
Posted May 9, 2016 at Policy and Medicine
Image
We have previously written about the way the American Board of Internal Medicine (ABIM) is seeking physician input on Maintenance of Certification (MOC) assessments. recently, ABIM announced the findings from that recent survey. All ABIM Board Certified physicians were invited... Continue reading
Posted May 6, 2016 at Policy and Medicine
Image
Day Two of the Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) was lively and full of debate and conversation. The day started out with comments... Continue reading
Posted May 5, 2016 at Policy and Medicine
Image
The Bipartisan Policy Center has plans to host three educational forums over the next several months, focused on the national conversation on affordable prescriptions. The purpose of these forums is to inform the conversation, and to help provide an understanding... Continue reading
Posted May 5, 2016 at Policy and Medicine
Image
This article provides an overview of the FDA's initiative to realign programs from location-centered structures and specializations to commodities specializations, and its impact on the implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA). The Food and... Continue reading
Posted May 5, 2016 at Policy and Medicine
Image
The Food and Drug Administration (FDA) is hosting a two-day long Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) to discuss results from assessments of the... Continue reading
Posted May 4, 2016 at Policy and Medicine
Image
The Annual Forums on Transparency and Aggregate Spend are coming up. The 7th Annual West Coast Forum on Transparency & Aggregate Spend will be held May 18-19, 2016 at the Westin in San Diego, CA. The 10th Annual Forum on... Continue reading
Posted May 4, 2016 at Policy and Medicine